Amendment Directive issued for the Prevention of COVID-19 Pandemic No 933/2022
One of those infectious diseases related to mobility is yellow fever. Ethiopia, both as being one of yellow fever endemic country, and a host to travelers arriving from other yellow fever endemic countries, has a mandatory yellow fever vaccine certificate regulation.
Country requirement at entry: proof of vaccination against yellow fever is required for travellers aged 9 months or over arriving from countries with risk of yellow fever transmission, and for travellers having transited for more than 12 hours through an airport of a country with risk of yellow fever transmission.
WHO vaccination recommendation: yes
Recommended for all travellers aged 9 months or over, except as mentioned below. Generally not recommended for travellers whose itineraries are limited to Afar and Somali provinces.
Malaria risk due to approximately 60% P. falciparum and 40% P. vivax exists throughout the year in the entire country below 2000 m. P. vivax resistance to chloroquine reported. There is no malaria risk in Addis Ababa.
WHO recommended prevention in risk areas: C
Malaria risk and type of prevention
|Malaria risk||Type of prevention|
|Type A||Very limited risk of malaria transmission||Mosquito-bite prevention only|
|Type B||Risk of non-falciparum malaria||Mosquito-bite prevention plus chloroquine, or doxycycline or atovaquone-proguanil or mefloquine chemoprophylaxis (select according to drug-resistance pattern, reported side-effects and contraindications)|
|Type C||Risk of P. falciparum malaria||Mosquito-bite prevention plus atovaquone-proguanil or doxycycline or mefloquine chemoprophylaxis (select according to drug-resistance pattern, reported side-effects and contraindications)|